Fifth Lane Capital »

Relmada Therapeutics shares owned by Fifth Lane Capital

Quarter-by-quarter ownership of Relmada Therapeutics (RLMD) shares owned by Fifth Lane Capital from 13F filings

Historical chart of Fifth Lane Capital investment in Relmada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Relmada Therapeutics held by Fifth Lane Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Relmada Therapeutics by Fifth Lane Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $313k 45k 6.96

More positions owned by Fifth Lane Capital

Renatus Tactical Acquis Shs Cl A (RTAC)
Onestream Cl A
Cantor Equity Partners V Shs Cl A S (CEPV)
Hologic
Cantor Equity Partners Ii In Cl A Ord Shs
New Amer Acquisition I Corp Unit 99/99/9999 (NWAX.U)
Electronic Arts (EA)
Arcellx Common Stock (ACLX)
Futurecrest Acquisition Corp Cl A Ord Shs (FCRS)
Listed Fds Tr Roundhill Magnif (MAGS)
New Amer Acquisition I Corp Com Shs Cl A (NWAX)
Futurecrest Acquisition Corp Unit 99/99/9999 (FCRS.U)
UnitedHealth (UNH)
Abivax Sa Sponsored Ads (ABVX)
Core Scientific (CORZ)

View all positions for Fifth Lane Capital

Top funds holding Relmada Therapeutics

Henderson Group
Squadron Capital Management
VR Adviser
Adage Capital Partners GP
OrbiMed Advisors
Marshall Wace
Millennium Management
Vanguard Capital Management
RA Capital Management
Ikarian Capital
Driehaus Capital Management
Ameriprise Financial
Polar Capital Holdings
Susquehanna International
BlackRock

View all funds holding Relmada Therapeutics